Publikationen

1.  Afshar-Oromieh,A,, Debus,N,, Uhrig,M,, Hope,TA,, Evans,MJ,, Holland-Letz,T,, Giesel,FL,, Kopka,K,, Hadaschik,B,, Kratochwil,C,, Haberkorn,U.: Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 45 (12), 2045-2054, 2018.

2.  Anwar,H., Sachpekidis,C., Winkler,J., Kopp-Schneider,A., Haberkorn,U., Hassel,J.C., Dimitrakopoulou-Strauss,A.: Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. European Journal of Nuclear Medicine and Molecular Imaging 45 (3), 376-383, 2018.

3.  Ahmadzadehfar,H., Essler,M., Rahbar,K., Afshar-Oromieh,A.: Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning. PET clinics 13 (4), 491-503, 2018.

4.  Baranski,AC., Schaefer,M., Bauder-Wuest,U., Roscher,M., Schmidt,J., Stenau,E., Simpfendorfer,T., Teber,D., Maier-Hein,L., Hadaschik,B., Haberkorn,U., Ede,M., Kopka,K.: PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer. Journal of Nuclear Medicine 59 (4), 639-645, 2018.

5.  Blaes ,J.*, Thome,CM*, Pfenning,PN., Rubmann,P., Sahm,F., Wick,A., Bunse,T., Schmenger,T., Sykora,J., von Deimling,A., Wiestler,B., Merz,C., Jugold,M., Haberkorn,U., Abdollahi,A., Debus,J., Gieffers,C., Kunz,C., Bendszus,M., Kluge,M., Platten,M., Fricke,H., Wick,W., Lemke,D., (*=Contributed equally): Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma. Molecular Cancer Research 16 (5), 767-776, 2018.

6.  Buder-Bakhaya,K., Benesova,K., Schulz,C., Anwar,H., Dimitrakopoulou-Strauss,A., Weber,T.F., Enk, A., Lorenz,H.M., Hassel,J.C.: Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies. Cancer Immunology Immunotherapy 67 (2), 175-182, 2018.

7.  Debus,C., Afshar-Oromieh,A., Floca,R., Ingrisch,M., Knoll,M., Debus,J., Haberkorn,U., Abdollahi,A.: Feasibility and robustness of dynamic (18)F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation. Scientific Reports 8 (1), 14760, 2018.

8.  Debus,C., Waltenberger,M., Floca,R., Afshar-Oromieh,A., Bougatf,N., Adeberg,S., Heiland,S., Bendszus,M., Wick,W., Rieken,S., Haberkorn,U., Debus,J., Knoll,M., Abdollahi,A.: Impact of (18)F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy. Scientific Reports 8 (1), 7201, 2018.

9.  Eiber,M., Herrmann,K., Calais,J., Hadaschihk,B., Giesel,FL., Hartenbach,M., Hope,T., Reiter,R., Maurer,T., Weber,WA., Fendler,WP.: PROstate cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT. Journal of Nuclear Medicine 59 (3), 469-478, 2018.

10.  Fanti,S., Minozzi,S., Antoch,G., Banks,I., Briganti,A., Carrio,I., Chiti,A., Clarke,N., Eiber,M., De Bono,J., Fizazi,K., Gillessen,S., Gledhill,S., Haberkorn,U., Herrmann,K., Hicks,RJ., Lecouvet,F., Montironi,R., Ost,P., O'Sullivan,JM., Padhani,AR., Schalken,JA., Scher,HI., Tombal,B., van Moorselaar,RJA., Van Poppel,H., Vargas,HA,, Walz,J., Weber,WA., Wester,HJ., Oyen,WJG.: Consensus on molecular imaging and theranostics in prostate cancer. Lancet Oncology 19 (12), E696-E708, 2018.

11.  Flechsig,P., Walker,C., Kratochwil,C., Konig,L., Iagura,A., Moltz,J., Holland-Letz,T., Kauczor,HU., Haberkorn,U., Giesel,FL.: Role of CT Density in PET/CT-Based Assessment of Lymphoma. Molecular Imaging and Biology 20 (4), 641-649, 2018.

12.  Flechsig,P., Rastgoo,R., Kratochwil,C., Martin,O., Holland-Letz,T., Harms,A., Kauczor,HU., Haberkorn,U., Giesel,FL.: Impact of Computer-Aided CT and PET Analysis on Non-invasive T Staging in Patients with Lung Cancer and Atelectasis. Molecular Imaging and Biology 20 (6), 1044-1052, 2018.

13.  Flechsig,P., Hural,O., Kreuter,M., Eichhorn,M., Heussel,G., Sachpekidis,C., Kauczor,HU., Haberkorn,U., Heussel,CP., Eichinger,M.: Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD. In Vivo 32 (6), 1457-1462, 2018.

14.  Freitag,MT., Kesch,C., Cardinale,J., Flechsig,P., Floca,R., Eiber,M., Bonekamp,D., Radtke,JP., Kratochwil,C., Kopka,K., Hohenfellner,M., Stenzinger,A., Schlemmer,HP., Haberkorn,U., Giesel,F.: Simultaneous whole-body (18)F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging 45 (3), 340-347, 2018.

15.  Giammarile,F., Muylle,K., Bolton,R.D., Kunikowska,J., Haberkorn,U., Oyen,W.: CORRECTION: Dosimetry in clinical radionuclide therapy: the devil is in the detail (vol 44, pg 1, 2017). European Journal of Nuclear Medicine and Molecular Imaging 45 (4), 676-676, 2018.

16.  Giesel,FL., Will,L., Lawal,I., Lengana,T., Kratochwil,C., Vorster,M., Neels,O., Reyneke,F., Haberkorn,U., Kopka,K., Sathekge,M.: Intraindividual Comparison of (18)F-PSMA-1007 and (18)F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study. Journal of Nuclear Medicine 59 (7), 1076-1080, 2018.

17.  Giesel,FL., Will,L., Paddubny,K., Kremer,C., Rathke,H., Radtke,JP., Kopka,K., Haufe,S., Haberkorn,U., Kratochwil,C.: [18F]PSMA-1007 PET Improves the Diagnosis of Local Recurrence and Lymph Node Metastases in a Prostate Cancer Patient With a History of Bilateral Hip Arthroplasty. Clinical Genitourinary Cancer 16 (2), 111-113, 2018.

18.  Giesel,FL., Will,L., Kesch,C., Freitag,M., Kremer,C., Merkle,J., Neels,OC., Cardinale,J., Hadaschik,B., Hohenfellner,M., Kopka,K., Haberkorn,U., Kratochwil,C.: Biochemical Recurrence of Prostate Cancer: Initial Results with [(18)F]PSMA-1007 PET/CT. Journal of Nuclear Medicine 59 (4), 632-635, 2018.

19.  Kesch,C., Radtke,J-P., Wintsche,A., Wiesenfarth,M., Luttje,M., Gasch,C., Dieffenbacher,S., Pecqueux,C., Teber,D., Hatiboglu,G., Nyarangi-Dix,J., Simpfendörfer,T., Schönberg,G., Dimitrakopoulou-Strauss,A., Freitag,M., Duensing,A., Grüllich,C., Jäger,D., Götz,M., Grabe,N., Schweiger, M-R., Pahernik,S., Perner,S., Herpel,E., Roth,W., Wieczorek,K., Maier-Hein,K., Debus,J., Haberkorn,U., Giesel,F., Galle,J., Hadaschik,B., Schlemmer,H-P., Hohenfellner,M., Bonekamp,D., Sültmann,H., Duensing,S.: Correlation between genomic index lesions and mpMRI and 68 Ga-PSMA-PET/CT imaging features in primary prostate cancer. Scientific Reports 8 (1), 16708, 2018.

20.  Kratochwil,C., Bruchertseifer,F., Rathke,H., Hohenfellner,M., Giesel,FL., Haberkorn,U., Morgenstern,A.: Targeted alpha-Therapy of Metastatic Castration-Resistant Prostate Cancer with (225)Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control. Journal of Nuclear Medicine 59 (5), 795-802, 2018.

21.  Kratochwil,C., Schmidt,K., Afshar-Oromieh,A., Bruchertseifer,F., Rathke,H., Morgenstern,A., Haberkorn,U., Giesel,F.L.: Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617. European Journal of Nuclear Medicine and Molecular Imaging 45 (1), 31-37, 2018.

22.  Larribere,L., Kuphal,S., Sachpekidis,C., Huser,L., Bosserhoff,A., Utikal,J.: Targeted Therapy-Resistant Melanoma Cells Acquire Transcriptomic Similarities with Human Melanoblasts. Cancers 10 (11), 2018. 

23.  Lindner,T., Loktev,A., Altmann,A., Giesel,F., Kratochwil,C., Debus,J., Jäger,D., Mier,W., Haberkorn,U.: Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. Journal of Nuclear Medicine 59 (9), 1415-1422, 2018.

24.  Loktev,A., Lindner,T., Mier,W., Debus,J., Altmann,A., Jäger,D., Giesel,F., Kratochwil,C., Barthe,P., Roumestand,C., Haberkorn,U.: A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. Journal of Nuclear Medicine 59 (9), 1423-1429, 2018.

25.  Liolios,C., Buchmuller,B., Bauder-Wuest,U., Schaefer,M., Leotta,K., Haberkorn,U., Eder,M., Kopka,K.: Monomeric and Dimeric (68)Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs). Journal of Medicinal Chemistry 61 (5), 2062-2074, 2018.

26.  Majenka,P., Hoffmann,M., Rötzer,I., Dimitrakopoulou-Strauss,A., Koschny,R., Longerich,T., Enk,A., Hassel,J.C..: Diet-dependent toxicity of ipilimumab in metastatic melanoma. European Journal of Cancer 106, 220-224, 2018.

27.  Mavriopoulou,E., Zampakis,P., Smpiliri,E., Spyridonidis,T., Rapti,E., Haberkorn,U., Makatsoris,T., Apostolopoulos,DJ.: Whole body bone SPET/CT can successfully replace the conventional bone scan in breast cancer patients. A prospective study of 257 patients. Hellenic Journal of Nuclear Medicine 21 (2), 125-133, 2018.

28.  Melzig,C., Fahim Golestaneh,A., Mier,W., Schwager,CD., Das,S., Schlege,J., Lasitschka,F., Kauczor,H.U., Debus,J., Haberkorn,U., Abdollahi,A.: Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapy. Oncotarget 9 (52), 29985-30004, 2018.

29. Paddubny,K., Freitag,M.T., Kratochwil,C., Koerber,S., Radtke,J.P., Sakovich,R., Kopka,K., Giesel,F.L.: Fluorine-18 Prostate-specific Membrane Antigen-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Diagnostics of Local Recurrence in a Prostate Cancer Patient After Recent Radical Prostatectomy. Clinical Genitourinary Cancer 16 (2), 103-105, 2018.

30.  Paech,D., Klopries,K., Doll,S., Nawrotzki,R., Schlemmer,HP., Giesel,FL., Kuner,T.: Contrast-enhanced cadaver-specific computed tomography in gross anatomy teaching. European Radiology 28 (7), 2838-2844, 2018.

31.  Rathke,H., Afshar-Oromieh,A., Giesel,FL., Kremer,C., Flechsig,P., Haufe,S., Mier,W., Holland-Letz,T., De Bucourt,M., Armor,T., Babich,JW., Haberkorn,U., Kratochwil,C.: Intraindividual Comparison of (99m)Tc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand (99m)Tc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer. Journal of Nuclear Medicine 59 (9), 1373-1379, 2018.

32.  Rathke,H., Giesel,FL., Flechsig,P., Kopka,K., Mier,W., Hohenfellner,M., Haberkorn,U., Kratochwil,C.: Repeated (177)Lu-Labeled PSMA-617 Radioligand Therapy Using Treatment Activities of Up to 9.3 GBq. Journal of Nuclear Medicine 59 (3), 459-465, 2018.

33.  Roesch,S., Lindner,T., Sauter,M., Loktev,A., Flechsig,P., Muller,M., Mier,W., Warta,R., Dyckhoff,G., Herold-Mende,C., Haberkorn,U., Altmann,A.: Comparison of the RGD Motif-Containing alphavbeta6 Integrin-Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC. Journal of Nuclear Medicine 59 (11), 1679-1685, 2018.

34.  Rohrich,M., Huang,K., Schrimpf,D., Albert,NL., Hielscher,T., von Deimling,A., Schuller,U., Dimitrakopoulou-Strauss,A., Haberkorn,U.: Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. European Journal of Nuclear Medicine and Molecular Imaging 45 (9), 1573-1584, 2018.

35.  Sachpekidis,C., Anwar,H., Winkler,J., Kopp-Schneider,A., Larribere,L., Haberkorn,U., Hassel,JC., Dimitrakopoulou-Strauss,A.: The role of interim (18)F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma. European Journal of Nuclear Medicine and Molecular Imaging 45 (8), 1289-1296, 2018.

36.  Sachpekidis,C., Pan,L., Hadaschik,B.A., Kopka,K., Haberkorn,U., Dimitrakopoulou-Strauss,A.: (68)Ga-PSMA-11 PET/CT in prostate cancer local recurrence: impact of early images and parametric analysis. Journal of Nuclear Medicine 8 (5), 351-359, 2018.

37.  Sachpekidis,C., Anwar,H., Winkler,J.K., Kopp-Schneider,A., Larribere,L., Haberkorn,U., Hassel,J.C., Dimitrakopoulou-Strauss,A.: Longitudinal studies of the F-18-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT. Cancer Immunology Immunotherapy 67 (8), 1261-1270, 2018.

38.  Sachpekidis,C., Baeumer,P., Kopka,K., Hadaschik,B.A., Hohenfellner,M., Kopp-Schneider,A., Haberkorn,U., Dimitrakopoulou-Strauss,A.: Ga-68-PSMA PET/CT in the evaluation of bone metastases in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 45 (6), 904-912, 2018.

39.  Sachpekidis,C., Goldschmidt,H., Kopka,K., Kopp-Schneider,A., Dimitrakopoulou-Strauss,A.: Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined F-18-FDG and F-18-FLT PET/CT imaging. EJNMMI Research 8, 2018.

40.  Sachpekidis,C., Sachpekidis,V., Moralidis,E., Arsos,G.: Equilibrium radionuclide ventriculography: still a clinically useful method for the assessment of cardiac function?. Hellenic Journal of Nuclear Medicine 21 (3), 213-220, 2018. [Version-Id: 92519; Published-Id: 92519; Kst: E060]

41.  Soldatos,TG., Dimitrakopoulou-Strauss,A., Larribere,L., Hassel,JC., Sachpekidis,C.: Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data. Diagnostics 8 (4), 2018.

42.  Taieb,D., Foletti,JM., Bardies,M., Rocchi,P., Hicks,RJ., Haberkorn,U.: PSMA-Targeted Radionuclide Therapy and Salivary Gland Toxicity: Why Does It Matter?. Journal of Nuclear Medicine 59 (5), 747-748, 2018.

43.  Zacho,HD., Nielsen,JB., Dettmann,K., Haberkorn,U., Langkilde,NC., Jensen,JB., Petersen,LJ.: 68Ga-PSMA PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: A Prospective, 2-Center Study. Clinical Nuclear Medicine 43 (8), 579-585, 2018.

44.  Zacho,HD., Nielsen,JB., Afshar-Oromieh,A., Haberkorn,U., deSouza,N., De Paepe,K., Dettmann,K., Langkilde,NC., Haarmark,C., Fisker,RV., Arp,DT., Carl,J., Jensen,JB., Petersen,LJ.: Prospective comparison of (68)Ga-PSMA PET/CT, (18)F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 45 (11), 1884-1897, 2018.

45.  Zacho,H.D., Nielsen,J.B., Haberkorn,U., Stenholt,L., Petersen,L.J.: 68 Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature. Clinical Physiology and Functional Imaging 38 (6), 911-922, 2018.

 

nach oben
powered by webEdition CMS